Our website is currently under construction, but we wanted to let you know we will be actively accepting Medicare, FL Medicaid, Self-Pay and additional private insurance patients in August 2026.

Below is an overview of our philosophy, treatment approach and care plans. Please click to review our Terms of Agreement for additional details and HIPPA privacy form. More to come! Please check back!

TERMS of SERVICE HIPPA PRIVACY STATEMENT HIPPA SUD PRIVACY

Questions? Please Email Us! (Be careful do not send personal info!!!!!)

More Info--

Our goal is to help you resume a normal life with you "In Charge" of the disease of Opioid Use Disorder.

Our Approach

We treat Opioid Use Disorder (OUD) as an acute on chronic medical condition—just like hypertensive crisis versus chronic high blood pressure. You may be or previously have been acutely ill with the effects and consequences of Opioid Abuse. We offer treatment and care to stabilize acute symptoms and ongoing suppression of cravings as well as strategies to take charge of triggers. Yes, the 1st day, 1st week and sometimes the 1st month of transitioning to Medication Assisted Treatment (MAT) can be really rough but we have a medication protocol including Buprenorphine/Naloxone and practical recommendations to help.

We take into account those who have been down that acute road, stabilized, and have a documented commitment to controlling the chronic disease of OUD with Buprenorphine/Naloxone can be managed with a chronic disease model every 3 months.

Outpatient Virtual MAT: We provide accessible outpatient Medication-Assisted Treatment (MAT) using a secure telemedicine platform and prescribing buprenorphine/naloxone for eligible patients residing in Florida. Note: MAT (buprenorphine/naloxone) is just one tool that must be combined with daily, practical, life strategies to put you in control of cravings, triggers and eliminate those risk factors for return to use.

Just taking a medicine will not help you control problematic, symptomatic opioid addiction.

Our Program consists of a acute on chronic disease approach using medical care. We personalize medical care based on what you are experiencing and safety concerns unique to each phase.

We screen those with problematic opioid use (both prescription and illicit/street) to safely convert them to MAT with Buprenorphine/Naloxone (aka Suboxone) initially with very frequent visits and contact. As acute symptoms improve, we assist by adjusting dosages, timing of doses to symptoms and identify triggers with strategies to reduce your risk of return to use with weekly then graduating to biweekly contact. As you gain control over symptoms and triggers in the following 6-8 weeks we begin to shift control to you. With success in controlling triggers and a demonstrated commitment to the program requirements you graduate to monthly and as needed contact. Around 18 months many people have stabilized and life has returned to normal. At that point we evaluate your options such as safe taper, converting to other medications, and/or carefully reviewing eligibility for our chronic disease/medication management program for chronic Buprenorphine/Naloxone--the Goal 90 Day Plan

Goal-90 Day Plan
Goal-90 Day Plan is a chronic disease management model for those with stable OUD that require ongoing medication to maintain stability with proven program commitment and measurable compliance.

Goal-90 Day Plan is designed for those who have been stable with documented commitment to the requirements of a ASAM Level I MAT program for a minimum of 18 months.

The Goal-90 Day Plan seeks to normalize MAT treatment by addressing as a chronic disease. It includes a commitment to follow the terms of agreement, attend telehealth visits and urine drug screening occurring every 3 months for approval of a 90-day prescription.

What if you have been stable on Buprenorphine/Naloxone for years?

If you have documented long-term stability (more than 2 years), are back to normal life, consistently demonstrate program commitment by achieving the terms of your MAT agreement your provider may consider a personalized fast-track from monthly to 90-day plan at 6 months.

Why? We get that stable OUD is a chronic disease and should be managed just like any other chronic disease (example high cholesterol).

What happens if I have a lapse or episode of return to use?

Sometimes people do great, but a few years later something bad happens. It may be a major illness, financial stressor, social issue or an attempt to self-wean off of buprenorphine/naloxone without medical supervision (that's a biggy sometimes due to costs or loss of insurance). Whatever, cravings may worsen and lead to a lapse (return to use). It also may be accompanied or triggered by a worsening of a previously stable psychiatric or medical problem. The scary thing is your body is no longer able to tolerate the prior problem substance, and you may OD on small amounts. So, if you even think this could possibly happen let us know so we can turn up the dial and provide more support, possibly increase buprenorphine/naloxone dose, before it actually happens. In these cases, we may increase monitoring by increasing visit frequency to every 2 weeks, with confirming urine drug screening, and changes in daily dose and amount prescribed until symptoms stabilize. Once source addressed and stability restored visit intervals return to monthly and you can get back on track to meet criteria to resume a 90-day schedule once safety, commitment and stability are assured. We will assist you to find additional resources to help such as a group, therapy or specialist referral. If illness or destabilizing event is very, very severe, we may refer you to an in-person MAT provider and accept you back with a referral recommendation.

Terms of Service

HIPPA Privacy Statement Part I HIPPA Privacy SUD Part 2

contact@inchargeclinic.com

Welcome to InChargeClinic!

Putting You "In Charge"

of the Acute on Chronic Disease of Opioid Use Disorder

Inchargeclinic offers the "Goal 90 Day" program for stabilized Florida Residents on long-term buprenorphine/naloxone for continued success with chronic control of Opioid Use Disorder. These individuals with documented long-term appropriate use, active prescriptions on PDMP, and a demonstrated commitment to continued control of OUD in compliance with the ICC program may be eligible for fast-track to the Goal 90 Day program.

Those individuals that require assistance to transition from active problem/hazardous opioid use (prescription or illicit/street) to medication assisted treatment with buprenorphine/naloxone are carefully screened for safety before induction (transition to buprenorphine/naloxone). Each individual is unique so we tailor follow-up based on need. At a minimum, they can expect to be seen every 2 weeks for the first 2-3 months, then monthly. Individuals demonstrating stability and commitment to program requirements become eligible for the Goal 90 Day program at approximately 18 months--a pivotal time in sustained recovery.